GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (BSP:N1VS34) » Definitions » Policy Acquisition Expense

Novartis AG (BSP:N1VS34) Policy Acquisition Expense


View and export this data going back to 2020. Start your Free Trial

What is Novartis AG Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Novartis AG (BSP:N1VS34) Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.